Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting Her 2neu positive localized Gastric Adenocarcinoma? | World Journal of Surgical Oncology BioMed Central Vz The Open Access Publisher This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text HTML versions will be made available soon. Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting Her 2neu positive localized Gastric Adenocarcinoma World Journal of Surgical Oncology 2011 9 112 doi 1477-7819-9-112 Yassir Sbitti sbittiyassir@ Ismail Essaidi ismail_onco@ Adil Debbagh dr_raulito@ Habiba Kadiri kadirihabiba@ Mohamed Oukabli oukablimohamed@ Yassine Moussaid infinityklass@ Khaoula Slimani Mohamed Fetohi haieme@ Hakim Elkaoui medfetohi@ Abderrahmane Albouzidi albouzidi@ Mohamed Mahi mahimohamed@ Abdelmounaim Ait Ali Mohamed Ichou medichou@ Hassan Errihani h_errihani@ ISSN 1477-7819 Article type Case report Submission date 22 June 2011 Acceptance date 28 September 2011 Publication date 28 September 2011 Article URL http content 9 1 112 This peer-reviewed article was published immediately upon acceptance. It can be downloaded printed and distributed freely for any purposes see copyright notice below . Articles in WJSO are listed in PubMed and archived at PubMed Central. For information about publishing your research in WJSO or any BioMed Central journal go to http authors instructions 2011 Sbitti et al. licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. W r dJ .urnal of Surgical Central Oncology V__z The Open Access Publisher For information about other BioMed Central publications go to http 2011
